Trump's Drug Czar Pick Calls Cannabis Rescheduling Bipartisan
- barneyelias0
- Sep 19
- 1 min read
Updated: Sep 22
OG Article By Anthony Martinelli in News
September 19 2025
Overview
Sara Carter, Trump's nominee for White House Office of National Drug Control Policy, called cannabis rescheduling a bipartisan issue in her Senate hearing.
Key Exchange
Senator Cory Booker (D-NJ) asked about moving cannabis from Schedule I to III under the Controlled Substances Act. He called it a step forward.
Booker noted Carter's past support for medical cannabis in 2023. He highlighted veterans' stories of cannabis helping with PTSD.
Booker said: “That would recognize medical benefits. It allows scientists to study health impacts. It opens doors to more research. If confirmed, how would you advise the president on rescheduling?”
Carter's Response
Carter said she sees it as bipartisan. She will rely on data and research.
“If confirmed, I will follow federal laws and ONDCP duties. We will use research and data. We will explore options.”
She mentioned talks with Veterans Affairs Secretary Doug Collins. The focus is on research and data for assessments.
Further Discussion
Booker criticized ONDCP limits on advocating Schedule I legalization. These hinder science. He asked if Carter supports laws allowing studies.
“Absolutely,” Carter replied. “We will study impacts.”
Background
The rescheduling started under Biden but paused by a judge. On August 11, Trump said a decision comes soon.
Comments